kidney disease
The company will use the funds to hasten the growth of its normothermic machine perfusion platform, metra.
The AKF and Ubie will fine-tune the digital health company's AI-enabled symptom checker to help accelerate kidney disease diagnosis.
The company will use the funds to support and grow its team, enhance its platform and expand partnerships with payors, health systems and physicians.
It can potentially help doctors prevent or better manage kidney disease in patients with Type 2 diabetes.
The funds will help expand the company's deployment of its in-home kidney and polychronic care delivery model and its clinical services.
This marks the urinalysis and wound-care company's third 510(k) clearance.
The website has been launched across 10 countries and in nine different languages.
This Series B round brings the company's total funding to $223.5 million.
Providers can tap into the tool for resources and collaboration.
While Scanwell is still expanding its consumer telehealth offering, it's also working to position itself as a broader "diagnostics as a service" partner to the healthcare industry.